Analytical development experts will address questions about regulatory requirements, stability and shipping studies in a complimentary webinar in May, sponsored by Patheon.
Hosted by Pharmaceutical Technology, the webinar 'Stability Assessment for Shipment of API and Drug Products' will provide guidance concerning the evaluation of APIs and drug product shipments.
The event will be held on Thursday 21 May from 11am to 12pm EDT.
Webinar participants will hear about the evolving regulatory expectations for stability studies, review challenges in global studies and learn how to improve strategies for biological stability studies.
The presenters are Patheon director of analytical development Geoff Carr, PhD, and senior manager of analytical development Vladimir Golynskiy, PhD.
They will discuss the approaches to assessing stability of biologic APIs and small-molecule drug products throughout expected product shipment.
The live webcast will be moderated by Pharmaceutical Technology editorial director Rita Peters.
